Moscow will strengthen control over the observance of the mask regime in shops and catering places, said Alexei Nemeryuk, head of the Moscow department of trade and services.
He stressed that control over the observance of the mask regime in the capital has been carried out since last year, this work has not stopped.
“In Moscow, mobile groups regularly check retail and catering facilities.
A number of large shopping centers have already received a warning this week.
And the work on monitoring the observance of the mask regime will be intensified and carried out even more intensively, ”TASS quoted him as saying.
Nemeryuk recalled that for violations of measures to prevent coronavirus infection, a fine of up to 1 million rubles and a suspension of activities for up to 90 days are provided.
Meanwhile, 22,236 cases of coronavirus were detected in Russia per day.
13,513 people have fully recovered, 779 have died.
In total, 7,443,149 cases of COVID-19 have been identified in Russia since the beginning of the pandemic.
To date, 6 618 117 people have recovered, 204 679 have died from complications that developed against the background of the coronavirus.
According to Rospotrebnadzor, over the entire period, more than 190.2 million laboratory tests for a new type of coronavirus infection were carried out, including 418 thousand in the last day.
1,257,326 people remain under medical supervision.
Also on russian.rt.com Virologist Altstein spoke about immunity in COVID-19 patients
In Moscow, 3387 new cases of COVID-19 were detected per day.
810 people were hospitalized, 61 patients died.
There are 339 people on mechanical ventilation in Moscow hospitals.
"Rapid Adjustment Mechanisms Needed"
During the meeting of the Security Council, Vladimir Putin called for the use of the developments obtained during the coronavirus pandemic to create an algorithm of actions in the event of a repetition of such scenarios.
The President noted that the epidemic of coronavirus infection around the world has led to serious restrictions in public life, to the closure of state borders, and a forced decline in business activity.
“Accordingly, we have implemented fundamentally new large-scale measures to support the economy and citizens.
But in such conditions, of course, mechanisms are needed to quickly adjust and tune the adopted plans and programs, ”the President said.
According to the head of state, Russia managed to introduce such changes, which worked quickly and efficiently.
“But it is necessary that this was not done in“ manual control ”, for the future, if such situations arise, but that we use the best practices we have in order to work out the algorithm of actions actually in automatic mode,” concluded the head of state ...
QR codes in the Samara region
The authorities of the Samara region, due to the situation with coronavirus infection, are introducing QR codes to visit a number of public places.
According to the head of the region, Dmitry Azarov, two weeks are given to organize the process.
© AP Photo / Pavel Golovkin
“As for cultural and leisure facilities and fitness centers, now they will receive visitors by the QR code of the vaccination certificate,” the governor wrote on Instagram.
In addition, the region was instructed to strengthen control over the observance of the mask regime, primarily in public transport and shopping centers.
It will also consider the feasibility of transferring students of the sixth to tenth grades to distance learning.
Clinical trials of the Betuvax vaccine
The Russian Ministry of Health approved the start of clinical trials of the Betuvax coronavirus vaccine, it follows from the department's register.
We are talking about a subunit recombinant vaccine based on spherical particles with a surface antigen SARS-CoV-2.
Also on russian.rt.com Russia is considering the possibility of creating a combined vaccine against influenza and coronavirus
Dosage form and dosage of the drug - suspension for intramuscular administration, 10 μg / ml, 40 μg / ml.
It is noted that the goal of clinical trials is "to assess the safety, tolerability and immunogenicity of Betuvax-CoV-2 in healthy adult volunteers."
According to one of the drug development companies, the first and second stages of clinical trials of Betuvax are planned to be completed in late February - early March 2022.
“The first step is to answer safety questions, and the second is to find the dosage.
The final conclusions are made after the third phase of clinical trials.
The preliminary report will take four months for sure, "TASS quotes Artur Isaev, chairman of the board of directors of one of the drug's developers, the Human Stem Cell Institute (HSCI).